首页 | 本学科首页   官方微博 | 高级检索  
检索        

吗氯贝胺与阿米替林对躯体化障碍的疗效观察
引用本文:李静.吗氯贝胺与阿米替林对躯体化障碍的疗效观察[J].中国民康医学,2004,16(3):148-148,159.
作者姓名:李静
作者单位:山东省济宁复退军人精神病院,山东,济宁,272101
摘    要:目的:比较吗氯贝胺(MCL)与阿米替林(AML)治疗躯体化障碍的疗效及不良反应。方法:将60例符号CCMD-3诊断标准的躯体障碍神经症患者,随机分为应用MCL(30例)或MAL(30例)治疗6周,采用Hamilton焦虑量表(HAMA)和副作用反应量表(TESS)评定疗效及不良反应。结果:MCL与AML对躯体化障碍均有疗效,两组间无显著性差异(P>0.05)。MCL副反应明显少于AML(P<0.01)。结论:MCI治疗躯体化障碍疗效确切,副作用少而轻,患者服药依从性好。

关 键 词:吗氯贝胺  阿米替林  躯体化障碍  疗效  不良反应  药物治疗
文章编号:1672-0369(2004)03-0148-02

A study of Moclomicle in the treatment of somatization disorders disorder compared withe Amitriptyine
Lijieng,The Dimobibilized Soldinrs Montal Hospitol of Jining Yanzhou ..A study of Moclomicle in the treatment of somatization disorders disorder compared withe Amitriptyine[J].medical journal of chinese peoples health,2004,16(3):148-148,159.
Authors:Lijieng  The Dimobibilized Soldinrs Montal Hospitol of Jining Yanzhou
Institution:Lijieng The Dimobibilized Soldinrs Montal Hospitol of Jining Yanzhou . 272101
Abstract:Objectiv: To compave the efficacy and side effects of moclobemicle (MCL) and amitriptyine (AML) in tredtment of somatization disorder. Methods: 60 patients who met with the criteria of CCMD- 3 for somatization disorders were randomly assigned to MCL and AML treatment for 6weeke. Efficacy and side effects were evaluated with Hamilton Anxiety Scale ( HAMA) and Treatment Emergent Symptoms Scale (TESS). Re-ssults: Both drugs, had marked efficacy in treatment of somatization disorer, MCL had fewer side effects than AML. Conclusion: I tis suggested that MCL wes effective in the treatment of somatization disorer and produced fewer side effiects.
Keywords:Moclobemicle  Amitripryinc  Somafization disorder
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号